血清sTREM-1在成人Still病中:疾病活动性的新生物标志物及慢性病程的潜在预测因子
本研究检测了108例成人Still病(AOSD)患者、88例类风湿关节炎(RA)患者和112名健康对照(HC)的血清sTREM-1水平。AOSD患者血清sTREM-1显著高于RA和HC,且与全身评分、铁蛋白、白细胞计数、CRP、IL-1β和IL-6相关。初始sTREM-1升高(>526.4475 pg/ml)是活动性AOSD患者慢性病程的独立危险因素,干扰TREM-1可减少中性粒细胞和单核细胞促炎因子分泌。
要点
- AOSD患者血清sTREM-1水平显著高于RA患者和健康对照。
- 血清sTREM-1与AOSD疾病活动性指标(全身评分、铁蛋白、CRP、IL-1β、IL-6等)相关。
- 初始sTREM-1>526.4475 pg/ml是活动性AOSD患者慢性病程的独立危险因素。
核心结论
- 血清sTREM-1水平与AOSD疾病活动性相关,初始sTREM-1升高是AOSD患者慢性病程的潜在预测因子。
研究设计与样本
- 研究检测了108例AOSD患者、88例RA患者和112名健康对照的血清sTREM-1水平,采用Spearman相关分析和多变量logistic回归分析。
主要发现
- AOSD患者血清sTREM-1水平显著高于RA患者和健康对照。
- 血清sTREM-1水平与全身评分、铁蛋白、白细胞计数、CRP、IL-1β和IL-6相关。
- 初始sTREM-1水平升高本身可区分发展为慢性病程与非慢性病程的患者。
- 初始sTREM-1水平>526.4475 pg/ml是活动性AOSD患者慢性病程的独立危险因素。
- 干扰TREM-1 engagement可减少活动性AOSD患者中性粒细胞和单核细胞分泌IL-1β、IL-6和TNF-α等促炎因子。
关键数值与推荐
- sTREM-1截断值>526.4475 pg/ml用于判断活动性AOSD患者慢性病程的独立风险。
临床怎么用
- 血清sTREM-1可作为评估AOSD疾病活动性的生物标志物。
- 初始血清sTREM-1水平可用于识别易发展为慢性病程的AOSD患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Triggering receptor expressed on myeloid cells-1 (TREM-1) is an amplifier of inflammatory signals. Recently, a soluble form of TREM-1 (sTREM-1) was described. This study aimed to investigate the role of serum sTREM-1 in patients with adult-onset Still's disease (AOSD). METHODS: Serum sTREM-1 levels were detected in 108 AOSD patients, 88 RA patients and 112 healthy controls (HC). The correlations of sTREM-1 with disease activity, clinical characteristics and laboratory parameters in AOSD patients were analysed by the Spearman correlation test. Risk factors for the chronic course of AOSD were evaluated by multivariate logistic regression analysis. RESULTS: AOSD patients had significantly higher serum sTREM-1 levels than RA patients and HC, and serum sTREM-1 levels were correlated with the systemic score, ferritin, leucocyte count, CRP, IL-1β and IL-6. The elevation in the initial sTREM-1 level by itself could discriminate patients developing the chronic course from patients developing the nonchronic course. Moreover, an elevated sTREM-1 level (> 526.4475 pg/ml) was an independent risk factor for the chronic course in active AOSD patients. Furthermore, interfering with TREM-1 engagement led to reductions in the secretion of pro-inflammatory cytokines, such as IL-1β, IL-6 and TNF-α, in neutrophils and monocytes from active AOSD patients. CONCLUSION: Serum sTREM-1 levels are correlated with disease activity, and an elevation in the initial serum sTREM-1 level is a potential predictor of the chronic course in AOSD patients, which currently provides the best predictive model for identifying patients prone to developing the chronic course of AOSD.
引用
- Wang Z, Chi H, Sun Y, et al. Serum sTREM-1 in adult-onset Still's disease: a novel biomarker of disease activity and a potential predictor of the chronic course. Rheumatology (Oxford). 2020. PMID: 32276274. doi:10.1093/rheumatology/keaa135
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。